Bedside testing for cancer.

A completely integrated microfluidic genetic analysis system with sample-in-answer-out capability In an accomplishment that represents a substantial step toward an era of rapid, inexpensive, bedside testing for cancer, researchers at the University of Virginia have developed a microfluidic device thatContinue reading… Bedside testing for cancer.

Bhaskar Kallakury.

Somewhat surprisingly, PCR analysis revealed that the primary laryngeal tumor lacked the mutant viral genome. To verify that the laryngeal site lacked this mutant genome, we utilized RCA to amplify and sequence the viral genome from the larynx. The producedContinue reading… Bhaskar Kallakury.